Pharma company Incyte is moving to the S&P 500, and the stock is rallying

Shares of Incyte rose more than 6 percent in Friday trade on news that the pharmaceutical company will join the S&P 500.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.